Organophosphorus Compounds and Oximes: a Critical Review

Overview

Journal Arch Toxicol

Specialty Toxicology

Date 2020 Jun 8

PMID 32506210

Citations 43

Authors

Franz Worek

Horst Thiermann

Timo Wille

Affiliations

Soon will be listed here.

Abstract

Organophosphorus (OP) pesticides and nerve agents still pose a threat to the population. Treatment of OP poisoning is an ongoing challenge and burden for medical services. Standard drug treatment consists of atropine and an oxime as reactivator of OP-inhibited acetylcholinesterase and is virtually unchanged since more than six decades. Established oximes, i.e. pralidoxime, obidoxime, TMB-4, HI-6 and MMB-4, are of insufficient effectiveness in some poisonings and often cover only a limited spectrum of the different nerve agents and pesticides. Moreover, the value of oximes in human OP pesticide poisoning is still disputed. Long-lasting research efforts resulted in the preparation of countless experimental oximes, and more recently non-oxime reactivators, intended to replace or supplement the established and licensed oximes. The progress of this development is slow and none of the novel compounds appears to be suitable for transfer into advanced development or into clinical use. This situation calls for a critical analysis of the value of oximes as mainstay of treatment as well as the potential and limitations of established and novel reactivators. Requirements for a straightforward identification of superior reactivators and their development to licensed drugs need to be addressed as well as options for interim solutions as a chance to improve the therapy of OP poisoning in a foreseeable time frame.

Citing Articles

Structure-activity studies of bispyridinium antinicotinics to select candidates to treat soman intoxication as part of a combined therapy.

Turner S, Timperley C, Bird M, Green A, Price M, Rice H PLoS One. 2025; 20(2):e0318508.

PMID: 39999134 PMC: 11856326. DOI: 10.1371/journal.pone.0318508.

Recent Development of Nanoparticle Platforms for Organophosphate Nerve Agent Detoxification.

Feng K, Zhang J, Shen W, Leng T, Zhou Z, Yu Y Langmuir. 2025; 41(4):2124-2140.

PMID: 39862147 PMC: 11803738. DOI: 10.1021/acs.langmuir.4c04637.

Supramolecular nanotherapeutics based on cucurbiturils.

Muheyati M, Wu G, Li Y, Pan Z, Chen Y J Nanobiotechnology. 2024; 22(1):790.

PMID: 39710716 PMC: 11664871. DOI: 10.1186/s12951-024-03024-z.

Model acetylcholinesterase-Fc fusion glycoprotein biotechnology system for the manufacture of an organophosphorus toxicant bioscavenging countermeasure.

Biel T, Faison T, Matthews A, Ortega-Rodriguez U, Falkowski V, Meek E Bioeng Transl Med. 2024; 9(5):e10666.

PMID: 39553427 PMC: 11561780. DOI: 10.1002/btm2.10666.

Organophosphate Poisoning: Review of Prognosis and Management.

Zoofaghari S, Maghami-Mehr A, Abdolrazaghnejad A Adv Biomed Res. 2024; 13:82.

PMID: 39512408 PMC: 11542695. DOI: 10.4103/abr.abr_393_22.

References

Sidell F, GROFF W . Toxogonin: blood levels and side effects after intramuscular administration in man. J Pharm Sci. 1970; 59(6):793-7. DOI: 10.1002/jps.2600590615. View

Spruit H, Langenberg J, Trap H, van der Wiel H, Helmich R, van Helden H . Intravenous and inhalation toxicokinetics of sarin stereoisomers in atropinized guinea pigs. Toxicol Appl Pharmacol. 2001; 169(3):249-54. DOI: 10.1006/taap.2000.9060. View

Sit R, Radic Z, Gerardi V, Zhang L, Garcia E, Katalinic M . New structural scaffolds for centrally acting oxime reactivators of phosphylated cholinesterases. J Biol Chem. 2011; 286(22):19422-30. PMC: 3103321. DOI: 10.1074/jbc.M111.230656. View

Tenberken O, Mikler J, Hill I, Weatherby K, Thiermann H, Worek F . Toxicokinetics of tabun enantiomers in anaesthetized swine after intravenous tabun administration. Toxicol Lett. 2010; 198(2):177-81. DOI: 10.1016/j.toxlet.2010.06.012. View

Sidell F . Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Clin Toxicol. 1974; 7(1):1-17. DOI: 10.3109/15563657408987971. View

Jokanovic M . Medical treatment of acute poisoning with organophosphorus and carbamate pesticides. Toxicol Lett. 2009; 190(2):107-15. DOI: 10.1016/j.toxlet.2009.07.025. View

Zorbaz T, Malinak D, Kuca K, Musilek K, Kovarik Z . Butyrylcholinesterase inhibited by nerve agents is efficiently reactivated with chlorinated pyridinium oximes. Chem Biol Interact. 2019; 307:16-20. DOI: 10.1016/j.cbi.2019.04.020. View

Kliachyna M, Santoni G, Nussbaum V, Renou J, Sanson B, Colletier J . Design, synthesis and biological evaluation of novel tetrahydroacridine pyridine- aldoxime and -amidoxime hybrids as efficient uncharged reactivators of nerve agent-inhibited human acetylcholinesterase. Eur J Med Chem. 2014; 78:455-67. DOI: 10.1016/j.ejmech.2014.03.044. View

Eddleston M, Street J, Self I, Thompson A, King T, Williams N . A role for solvents in the toxicity of agricultural organophosphorus pesticides. Toxicology. 2012; 294(2-3):94-103. PMC: 3325481. DOI: 10.1016/j.tox.2012.02.005. View

10.

Aurbek N, Herkert N, Koller M, Thiermann H, Worek F . Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?. Chem Biol Interact. 2010; 187(1-3):215-9. DOI: 10.1016/j.cbi.2010.01.035. View

11.

Clement J, Bailey D, MADILL H, Tran L, Spence J . The acetylcholinesterase oxime reactivator HI-6 in man: pharmacokinetics and tolerability in combination with atropine. Biopharm Drug Dispos. 1995; 16(5):415-25. DOI: 10.1002/bdd.2510160506. View

12.

Dawson R . Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol. 1994; 14(5):317-31. DOI: 10.1002/jat.2550140502. View

13.

Xue S, Ding X, Ding Y . Clinical observation and comparison of the effectiveness of several oxime cholinesterase reactivators. Scand J Work Environ Health. 1985; 11 Suppl 4:46-8. View

14.

Eddleston M, Szinicz L, Eyer P, Buckley N . Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. QJM. 2002; 95(5):275-83. PMC: 1475922. DOI: 10.1093/qjmed/95.5.275. View

15.

Finkelstein Y, Kushnir A, Raikhlin-Eisenkraft B, Taitelman U . Antidotal therapy of severe acute organophosphate poisoning: a multihospital study. Neurotoxicol Teratol. 1989; 11(6):593-6. DOI: 10.1016/0892-0362(89)90044-5. View

16.

Bentur Y, Layish I, Krivoy A, Berkovitch M, Rotman E, Haim S . Civilian adult self injections of atropine-trimedoxime (TMB4) auto-injectors. Clin Toxicol (Phila). 2006; 44(3):301-6. DOI: 10.1080/15563650600584519. View

17.

Rosenberg Y, Wang J, Ooms T, Rajendran N, Mao L, Jiang X . Post-exposure treatment with the oxime RS194B rapidly reactivates and reverses advanced symptoms of lethal inhaled paraoxon in macaques. Toxicol Lett. 2017; 293:229-234. PMC: 5943181. DOI: 10.1016/j.toxlet.2017.10.025. View

18.

Radic Z, Sit R, Kovarik Z, Berend S, Garcia E, Zhang L . Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases. J Biol Chem. 2012; 287(15):11798-809. PMC: 3320928. DOI: 10.1074/jbc.M111.333732. View

19.

Seeger T, Niessen K, Langer P, Gerhardus J, Worek F, Friess H . Restoration of nerve agent inhibited muscle force production in human intercostal muscle strips with HI 6. Toxicol Lett. 2011; 206(1):72-6. DOI: 10.1016/j.toxlet.2011.07.016. View

20.

Boskovic B . The treatment of Soman poisoning and its perspectives. Fundam Appl Toxicol. 1981; 1(2):203-13. DOI: 10.1016/s0272-0590(81)80059-0. View